IDEAYA Biosciences (IDYA) Other Non-Current Assets (2018 - 2026)

IDEAYA Biosciences has disclosed Other Non-Current Assets across 9 years of filings, most recently posting $1.3 million for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $1.3 million, up 59.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (up 59.13% YoY), and the FY2025 annual result was $1.0 million, up 26.09% from the prior year.
• Other Non-Current Assets came in at $1.3 million for Q1 2026 at IDEAYA Biosciences, up from $1.0 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $1.3 million in Q1 2026 to a low of $25000.0 in Q4 2023.
• The 5-year median for Other Non-Current Assets is $757000.0 (2024), against an average of $593352.9.
• Across the five-year window, Other Non-Current Assets sank 86.6% in 2022 and surged 3120.0% in 2024, its largest moves.
• IDEAYA Biosciences' Other Non-Current Assets stood at $99000.0 in 2022, then plunged by 74.75% to $25000.0 in 2023, then surged by 3120.0% to $805000.0 in 2024, then grew by 26.09% to $1.0 million in 2025, then grew by 26.21% to $1.3 million in 2026.
• The last three Other Non-Current Assets figures came in at $1.3 million (Q1 2026), $1.0 million (Q4 2025), and $805000.0 (Q3 2025), per Business Quant data.